US buys up world stock of key Covid-19 drug remdesivir
No other country will be able to buy remdesivir, which can help recovery from Covid-19, for next three months at least
- Coronavirus – latest US updates
- Coronavirus – latest updates
- See all our coronavirus coverage
The US has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against Covid-19, leaving none for the UK, Europe or most of the rest of the world.
Experts and campaigners are alarmed both by the US unilateral action on remdesivir and the wider implications, for instance in the event of a vaccine becoming available. The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.